Showing results (441-450 of 478) with videos related to
Sort By:
Pageof 48
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 ExpressionAparna Ningombam, Deepak Verma, Rajive Kumar, et al.JCO Global Oncology|May 13, 2022
Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in IndiaSudhir Kumar, Atul Sharma, Raja Pramanik, et al.Ecancermedicalscience|December 3, 2025
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH studyGhazal Tansir, Akhil Santhosh, Akash Kumar, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|June 23, 2012
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapesPasquale Niscola, Andrea Tendas, Luca Cupelli, et al.American Journal of Blood Research|November 23, 2020
MEF2C expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemiaJay Singh, Rajive Kumar, Deepak Verma, et al.Journal of Cancer Research and Therapeutics|March 30, 2024
Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colonJayati Sarangi, Prasenjit Das, Aijaz Ahmad, et al.Clinical Lymphoma, Myeloma & Leukemia|May 22, 2022
Multiple Myeloma: Impact of Time to Transplant on the OutcomeLalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, et al.The Indian Journal of Medical Research|September 10, 2019
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcomeLalit Kumar, Dev Ramavath, Babita Kataria, et al.Clinical Hematology International|October 1, 2021
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple MyelomaLalit Kumar, Santosh Kumar Chellapuram, Ramavat Dev, et al.Journal of the American Society of Nephrology : JASN|July 22, 2017
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody DevelopmentChris Wiebe, David N Rush, Thomas E Nevins, et al.Pageof 48